• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨 obscurin 通过 RhoA 依赖性细胞骨架重塑调控胰腺癌的迁移和转移。

Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer.

机构信息

Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD, USA.

Department of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD, USA; Institute for NanoBioTechnology, The Johns Hopkins University, Baltimore, MD, USA.

出版信息

Cancer Lett. 2022 Feb 1;526:155-167. doi: 10.1016/j.canlet.2021.11.016. Epub 2021 Nov 23.

DOI:10.1016/j.canlet.2021.11.016
PMID:34826548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9427004/
Abstract

Obscurins, encoded by the OBSCN gene, are giant cytoskeletal proteins with structural and regulatory roles. Large scale omics analyses reveal that OBSCN is highly mutated across different types of cancer, exhibiting a 5-8% mutation frequency in pancreatic cancer. Yet, the functional role of OBSCN in pancreatic cancer progression and metastasis has to be delineated. We herein show that giant obscurins are highly expressed in normal pancreatic tissues, but their levels are markedly reduced in pancreatic ductal adenocarcinomas. Silencing of giant obscurins in non-tumorigenic Human Pancreatic Ductal Epithelial (HPDE) cells and obscurin-expressing Panc5.04 pancreatic cancer cells induces an elongated, spindle-like morphology and faster cell migration via cytoskeletal remodeling. Specifically, depletion of giant obscurins downregulates RhoA activity, which in turn results in reduced focal adhesion density, increased microtubule growth rate and faster actin dynamics. Although OBSCN knockdown is not sufficient to induce de novo tumorigenesis, it potentiates tumor growth in a subcutaneous implantation model and exacerbates metastasis in a hemispleen murine model of pancreatic cancer metastasis, thereby shortening survival. Collectively, these findings reveal a critical role of giant obscurins as tumor suppressors in normal pancreatic epithelium whose loss of function induces RhoA-dependent cytoskeletal remodeling, and promotes cell migration, tumor growth and metastasis.

摘要

obscurins,由 OBSCN 基因编码,是具有结构和调节作用的巨大细胞骨架蛋白。大规模组学分析表明,OBSCN 在不同类型的癌症中高度突变,在胰腺癌中表现出 5-8%的突变频率。然而,OBSCN 在胰腺癌进展和转移中的功能作用尚待阐明。我们在此表明,巨大 obscurins 在正常胰腺组织中高度表达,但在胰腺导管腺癌中其水平明显降低。在非肿瘤性人胰腺导管上皮 (HPDE) 细胞和 obscurin 表达的 Panc5.04 胰腺癌细胞中沉默 giant obscurins 会诱导细胞形态拉长、呈纺锤形,并通过细胞骨架重塑导致更快的细胞迁移。具体而言, giant obscurins 的缺失会下调 RhoA 活性,从而导致焦点黏附密度降低、微管生长速度增加和肌动蛋白动力学加快。尽管 OBSCN 敲低不足以诱导新的肿瘤发生,但它在皮下植入模型中增强了肿瘤生长,并在胰腺癌转移的半脾小鼠模型中加剧了转移,从而缩短了生存时间。总之,这些发现揭示了 giant obscurins 在正常胰腺上皮中作为肿瘤抑制因子的关键作用,其功能丧失会诱导 RhoA 依赖性细胞骨架重塑,并促进细胞迁移、肿瘤生长和转移。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/132d830c476f/nihms-1823049-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/67ace172e9af/nihms-1823049-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/40458d7ff082/nihms-1823049-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/b7a02e560750/nihms-1823049-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/051448bed128/nihms-1823049-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/132d830c476f/nihms-1823049-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/67ace172e9af/nihms-1823049-f0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/40458d7ff082/nihms-1823049-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/b7a02e560750/nihms-1823049-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/051448bed128/nihms-1823049-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/609a/9427004/132d830c476f/nihms-1823049-f0005.jpg

相似文献

1
Giant obscurin regulates migration and metastasis via RhoA-dependent cytoskeletal remodeling in pancreatic cancer.巨 obscurin 通过 RhoA 依赖性细胞骨架重塑调控胰腺癌的迁移和转移。
Cancer Lett. 2022 Feb 1;526:155-167. doi: 10.1016/j.canlet.2021.11.016. Epub 2021 Nov 23.
2
Loss of giant obscurins from breast epithelium promotes epithelial-to-mesenchymal transition, tumorigenicity and metastasis.乳腺上皮细胞中巨大 obscurin 蛋白的缺失会促进上皮 - 间充质转化、肿瘤发生和转移。
Oncogene. 2015 Aug 6;34(32):4248-59. doi: 10.1038/onc.2014.358. Epub 2014 Nov 10.
3
A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.足细胞蛋白-动力蛋白 2 直接相互作用调控细胞骨架动力学促进胰腺癌细胞迁移和转移。
Cancer Res. 2019 Jun 1;79(11):2878-2891. doi: 10.1158/0008-5472.CAN-18-3369. Epub 2019 Apr 11.
4
Obscurin: A multitasking giant in the fight against cancer. obscurin:抗癌大战中的多面手。
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188567. doi: 10.1016/j.bbcan.2021.188567. Epub 2021 May 18.
5
Loss of the obscurin-RhoGEF downregulates RhoA signaling and increases microtentacle formation and attachment of breast epithelial cells.obscurin-RhoGEF 的缺失会下调 RhoA 信号传导,并增加乳腺上皮细胞的微触手形成和附着。
Oncotarget. 2014 Sep 30;5(18):8558-68. doi: 10.18632/oncotarget.2338.
6
Giant obscurins regulate the PI3K cascade in breast epithelial cells via direct binding to the PI3K/p85 regulatory subunit.巨大 obscurins 通过直接结合 PI3K/p85 调节亚基来调节乳腺上皮细胞中的 PI3K 级联反应。
Oncotarget. 2016 Jul 19;7(29):45414-45428. doi: 10.18632/oncotarget.9985.
7
Loss of giant obscurins promotes breast epithelial cell survival through apoptotic resistance.巨型 obscurins 的缺失通过抗细胞凋亡促进乳腺上皮细胞存活。
FASEB J. 2012 Jul;26(7):2764-75. doi: 10.1096/fj.12-205419. Epub 2012 Mar 21.
8
Obscurins: Goliaths and Davids take over non-muscle tissues.obscurins蛋白:巨人和大卫接管非肌肉组织
PLoS One. 2014 Feb 6;9(2):e88162. doi: 10.1371/journal.pone.0088162. eCollection 2014.
9
I told you to stop: obscurin's role in epithelial cell migration.我告诉过你停下: obscurin 在上皮细胞迁移中的作用。
Biochem Soc Trans. 2024 Aug 28;52(4):1947-1956. doi: 10.1042/BST20240564.
10
restoration via  long-noncoding RNA CRISPR-targeting suppresses metastasis in triple-negative breast cancer.通过长非编码 RNA CRISPR 靶向抑制恢复抑制三阴性乳腺癌转移。
Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2215553120. doi: 10.1073/pnas.2215553120. Epub 2023 Mar 6.

引用本文的文献

1
Multi-Omic Analysis Identifies Key Genes Driving Testicular Fusion in .多组学分析确定了驱动……睾丸融合的关键基因。 (原文句末不完整)
Int J Mol Sci. 2025 Jun 10;26(12):5564. doi: 10.3390/ijms26125564.
2
Tumor-derived exosomal CCT6A serves as a matchmaker introducing chemokines to tumor-associated macrophages in pancreatic ductal adenocarcinoma.肿瘤来源的外泌体CCT6A充当媒人,将趋化因子引入胰腺导管腺癌中的肿瘤相关巨噬细胞。
Cell Death Dis. 2025 May 15;16(1):382. doi: 10.1038/s41419-025-07720-y.
3
Loss of OBSCN expression promotes bladder cancer progression but enhances the efficacy of PD-L1 inhibitors.OBSCN表达缺失促进膀胱癌进展,但增强PD-L1抑制剂的疗效。
Cell Biosci. 2025 Mar 27;15(1):40. doi: 10.1186/s13578-025-01379-w.
4
Selective Modulation of Osteoclast Function by Venom and Its Fractions: Implications for Therapeutic Targeting in Bone Diseases.毒液及其组分对破骨细胞功能的选择性调节:对骨疾病治疗靶点的启示
Toxins (Basel). 2025 Mar 15;17(3):141. doi: 10.3390/toxins17030141.
5
Genomic characteristics and prognostic correlations in Chinese multiple myeloma patients.中国多发性骨髓瘤患者的基因组特征与预后相关性
BMC Med Genomics. 2025 Mar 14;18(1):50. doi: 10.1186/s12920-025-02116-5.
6
Genomic Characterization of High-Grade Serous Ovarian Carcinoma Reveals Distinct Somatic Features in Black Individuals.高级别浆液性卵巢癌的基因组特征揭示了黑人个体独特的体细胞特征。
Cancer Res. 2025 May 2;85(9):1725-1737. doi: 10.1158/0008-5472.CAN-24-1879.
7
Molecular mechanisms and clinicopathological characteristics of inhibin βA in thyroid cancer metastasis.抑素βA 在甲状腺癌转移中的分子机制及临床病理特征。
Int J Mol Med. 2024 Nov;54(5). doi: 10.3892/ijmm.2024.5423. Epub 2024 Sep 20.
8
Mdm2 requires Sprouty4 to regulate focal adhesion formation and metastasis independent of p53.Mdm2 需要 Sprouty4 来调节黏着斑形成和转移,而不依赖于 p53。
Nat Commun. 2024 Aug 20;15(1):7132. doi: 10.1038/s41467-024-51488-2.
9
Comprehensive somatic mutational analysis in glioblastoma: Implications for precision medicine approaches.胶质母细胞瘤的全面体细胞突变分析:对精准医疗方法的启示。
PLoS One. 2024 Jan 2;19(1):e0295698. doi: 10.1371/journal.pone.0295698. eCollection 2024.
10
Septin11 promotes hepatocellular carcinoma cell motility by activating RhoA to regulate cytoskeleton and cell adhesion.Septin11 通过激活 RhoA 调节细胞骨架和细胞黏附促进肝癌细胞迁移。
Cell Death Dis. 2023 Apr 20;14(4):280. doi: 10.1038/s41419-023-05726-y.

本文引用的文献

1
The fluid shear stress sensor TRPM7 regulates tumor cell intravasation.流体剪切应力传感器TRPM7调节肿瘤细胞内渗。
Sci Adv. 2021 Jul 9;7(28). doi: 10.1126/sciadv.abh3457. Print 2021 Jul.
2
Obscurin: A multitasking giant in the fight against cancer. obscurin:抗癌大战中的多面手。
Biochim Biophys Acta Rev Cancer. 2021 Aug;1876(1):188567. doi: 10.1016/j.bbcan.2021.188567. Epub 2021 May 18.
3
Hydraulic resistance induces cell phenotypic transition in confinement.水力阻力在受限环境中诱导细胞表型转变。
Sci Adv. 2021 Apr 23;7(17). doi: 10.1126/sciadv.abg4934. Print 2021 Apr.
4
Estimated Projection of US Cancer Incidence and Death to 2040.预估 2040 年美国癌症发病与死亡人数。
JAMA Netw Open. 2021 Apr 1;4(4):e214708. doi: 10.1001/jamanetworkopen.2021.4708.
5
Dorsoventral polarity directs cell responses to migration track geometries.背腹极性指导细胞对迁移轨迹几何形状的反应。
Sci Adv. 2020 Jul 31;6(31):eaba6505. doi: 10.1126/sciadv.aba6505. eCollection 2020 Jul.
6
Confinement hinders motility by inducing RhoA-mediated nuclear influx, volume expansion, and blebbing. confinement 通过诱导 rhoa 介导的核内流、体积膨胀和起泡来阻碍运动。
J Cell Biol. 2019 Dec 2;218(12):4093-4111. doi: 10.1083/jcb.201902057. Epub 2019 Nov 5.
7
A microfluidic assay for the quantification of the metastatic propensity of breast cancer specimens.一种用于定量检测乳腺癌标本转移倾向的微流控分析方法。
Nat Biomed Eng. 2019 Jun;3(6):452-465. doi: 10.1038/s41551-019-0400-9. Epub 2019 May 6.
8
A Direct Podocalyxin-Dynamin-2 Interaction Regulates Cytoskeletal Dynamics to Promote Migration and Metastasis in Pancreatic Cancer Cells.足细胞蛋白-动力蛋白 2 直接相互作用调控细胞骨架动力学促进胰腺癌细胞迁移和转移。
Cancer Res. 2019 Jun 1;79(11):2878-2891. doi: 10.1158/0008-5472.CAN-18-3369. Epub 2019 Apr 11.
9
Molecular subtypes of pancreatic cancer.胰腺癌的分子亚型。
Nat Rev Gastroenterol Hepatol. 2019 Apr;16(4):207-220. doi: 10.1038/s41575-019-0109-y.
10
Therapeutic developments in pancreatic cancer: current and future perspectives.胰腺癌的治疗进展:现状与未来展望。
Nat Rev Gastroenterol Hepatol. 2018 Jun;15(6):333-348. doi: 10.1038/s41575-018-0005-x.